These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37610445)

  • 21. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer.
    He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z
    Front Immunol; 2022; 13():835630. PubMed ID: 35401554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
    Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
    Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical nomogram based on absolute count of lymphocyte subsets for predicting overall survival in patients with non-small cell lung cancer.
    Liu A; Zhang G; Yang Y; Xia Y; Li W; Liu Y; Cui Q; Wang D; Zhao J; Yu J
    Int Immunopharmacol; 2023 Jan; 114():109391. PubMed ID: 36508919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Tamagawa A; Kazama K; Kato A; Cho H; Nakazono M; Numata M; Kawahara S; Tanabe M; Morita J; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Apr; 44(4):1629-1636. PubMed ID: 38537973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
    Xie D; Allen MS; Marks R; Jiang G; Sun Z; Nichols F; Zhang M; Chen C; Aubry MC; Jatoi A; Garces YI; Mansfield A; Wigle D; Molina J; Deschamps C; Yang P
    Eur J Cardiothorac Surg; 2018 Jun; 53(6):1214-1222. PubMed ID: 29293957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Numata M; Tamagawa A; Fukuda M; Cho H; Morita J; Yoshizawa S; Otani K; Kato A; Tanabe M; Nakazono M; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    Anticancer Res; 2024 Feb; 44(2):815-822. PubMed ID: 38307573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy.
    Wang Y; Qu X; Kam NW; Wang K; Shen H; Liu Q; Du J
    BMC Cancer; 2018 Jun; 18(1):692. PubMed ID: 29940884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological features and prognostic nomogram of giant cell carcinoma of the lung: A population-based study.
    He J; Ni JP; Li GB; Yao J; Ni B
    Clin Respir J; 2023 Mar; 17(3):197-210. PubMed ID: 36718941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and Validation of a Prognostic Model to Predict Overall Survival for Lung Adenocarcinoma: A Population-Based Study From the SEER Database and the Chinese Multicenter Lung Cancer Database.
    Wang Z; Hu F; Chang R; Yu X; Xu C; Liu Y; Wang R; Chen H; Liu S; Xia D; Chen Y; Ge X; Zhou T; Zhang S; Pang H; Fang X; Zhang Y; Li J; Hu K; Cai Y
    Technol Cancer Res Treat; 2022; 21():15330338221133222. PubMed ID: 36412085
    [No Abstract]   [Full Text] [Related]  

  • 30. Development and validation of a nomogram for predicting overall survival of resected N2 non-small cell lung cancer patients undergoing neoadjuvant radiotherapy.
    Shi J; Peng B; Wang C; Zhou X; Lu T; Xu R; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11779-11790. PubMed ID: 37407846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum hepatitis B viral (HBV) DNA is a predictive biomarker for survival in non-small cell lung cancer patients with chronic HBV infection.
    Fu Y; Yang X; Liang H; Wu X
    Cancer Manag Res; 2019; 11():5091-5100. PubMed ID: 31213920
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical predictive value of the CRP-albumin-lymphocyte index for prognosis of critically ill patients with sepsis in intensive care unit: a retrospective single-center observational study.
    Zhang J; Zhao Q; Liu S; Yuan N; Hu Z
    Front Public Health; 2024; 12():1395134. PubMed ID: 38841671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A predictive model based on liquid biopsy for non-small cell lung cancer to assess patient's prognosis: Development and application.
    Gu T; Ren J; Hu Z; Wei Y; Huang J
    Tissue Cell; 2022 Aug; 77():101854. PubMed ID: 35752028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and Validation of a Novel Nomogram to Predict the Overall Survival of Patients With Combined Small Cell Lung Cancer: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Jiang A; Liu N; Zhao R; Liu S; Gao H; Wang J; Zheng X; Ren M; Fu X; Liang X; Tian T; Ruan Z; Yao Y
    Cancer Control; 2021; 28():10732748211051228. PubMed ID: 34632799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
    Wei LJ; Hou Q; Yao NN; Liang Y; Cao X; Sun BC; Li HW; Liu JT; Xu SM; Cao J
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(17):1283-1289. PubMed ID: 35488697
    [No Abstract]   [Full Text] [Related]  

  • 38. Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study.
    Liu Y; Sun M; Xiong Y; Gu X; Zhang K; Liu L
    Technol Cancer Res Treat; 2022; 21():15330338221132035. PubMed ID: 36217877
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and validation of prognostic nomogram for T
    Mei W; Yao W; Song Z; Jiao W; Zhu L; Huang Q; An C; Shi J; Yu G; Sun P; Zhang Y; Shen J; Xu C; Yang H; Wang Q; Zhu Z
    BMC Cancer; 2023 Jul; 23(1):715. PubMed ID: 37525124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.
    Hashimoto I; Tanabe M; Onuma S; Morita J; Nagasawa S; Maezawa Y; Kanematsu K; Aoyama T; Yamada T; Yukawa N; Ogata T; Rino Y; Saito A; Oshima T
    In Vivo; 2024; 38(2):911-916. PubMed ID: 38418120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.